![David Campbell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Campbell
Fondateur chez
JANUX THERAPEUTICS, INC.
Fortune : 4 M $ au 31/07/2026
Profil
David Campbell is the founder of Janux Therapeutics, Inc., founded in 2017, where the title held is President, Chief Executive Officer & Director.
Dr. Campbell is also the founder of Thyritope Biosciences, Inc.,Adrenergics, Inc...
Former jobs include President & Chief Executive Officer at Enlibrium, Inc. from 2015 to 2017; Director-Discovery Chemistry at Bayer Corp.; Director-Discovery Chemistry at Affymax Research Institute; Senior Vice President-Drug Discovery & Development at Phenomix Corp.
from 2003 to 2010; Chief Scientific Officer at Afraxis, Inc.; Senior Vice President-Chemical Sciences at ActivX Biosciences, Inc. in 2003; Chief Scientific Officer at Sitari Pharma, Inc. from 2013 to 2019; and Chief Scientific Officer at Iron Horse Therapeutics, Inc. from 2015 to 2019.
Education includes undergraduate studies at Harvey Mudd College and graduate and doctorate degrees from Cornell University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/07/2026 | 264 742 ( 0,44% ) | 4 M $ | 31/07/2026 |
Postes actifs de David Campbell
| Sociétés | Poste | Début |
|---|---|---|
| JANUX THERAPEUTICS, INC. | Fondateur | 01/06/2017 |
Anciens postes connus de David Campbell
| Sociétés | Poste | Fin |
|---|---|---|
Sitari Pharma, Inc.
 Sitari Pharma, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services | Directeur Technique/Scientifique/R&D | 01/08/2019 |
Iron Horse Therapeutics, Inc.
 Iron Horse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develop drugs for amyotrophic lateral sclerosis | Directeur Technique/Scientifique/R&D | 01/06/2019 |
Enlibrium, Inc.
 Enlibrium, Inc. Medical/Nursing ServicesHealth Services Provides medical services | Directeur Général | 01/12/2017 |
Phenomix Corp.
 Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Corporate Officer/Principal | 28/10/2010 |
ActivX Biosciences, Inc.
 ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drug molecule for hematology, oncology, metabolic and inflammatory diseases | Corporate Officer/Principal | 01/05/2003 |
Formation de David Campbell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
Phenomix Corp.
Phenomix Corp. Pharmaceuticals: MajorHealth Technology Develops and discovers drugs | Health Technology |
Afraxis, Inc.
 Afraxis, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of fragile X syndrome and autism | Health Technology |
Affymax Research Institute
 Affymax Research Institute Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
ActivX Biosciences, Inc.
ActivX Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drug molecule for hematology, oncology, metabolic and inflammatory diseases | Health Technology |
Harvey Mudd College
 Harvey Mudd College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sitari Pharma, Inc.
Sitari Pharma, Inc. BiotechnologyHealth Technology Provides pharmaceutical research and development services | Health Technology |
Thyritope Biosciences, Inc.
 Thyritope Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics that target thyroid stimulating auto-antibodies | Health Technology |
Adrenergics, Inc.
 Adrenergics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics to treat dilated cardiomyopathy | Health Technology |
Enlibrium, Inc.
Enlibrium, Inc. Medical/Nursing ServicesHealth Services Provides medical services | Health Services |
Iron Horse Therapeutics, Inc.
Iron Horse Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develop drugs for amyotrophic lateral sclerosis | Health Technology |
Janux Therapeutics, Inc.
 Janux Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops precision engineered immunotherapies | Health Technology |
